1. Fetal disseminated intravascular coagulopathy, hydrops and massive umbilical vein thrombosis consequence of a rare placental condition: multifocal chorangiomatosis
- Author
-
Gennaro Scutiero, Danila Morano, Silvia Catagini, Stefania Carlucci, Guglielmo Stabile, Chiara Borghi, and Pantaleo Greco
- Subjects
Vascular Endothelial Growth Factor A ,hydrops ,Umbilical Veins ,Pathology ,medicine.medical_specialty ,Placenta Diseases ,Placenta ,villous capillary lesions ,Umbilical vein ,NO ,coagulopathy ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,medicine ,Coagulopathy ,Edema ,Humans ,Placenta Growth Factor ,Placental condition ,Fetus ,030219 obstetrics & reproductive medicine ,Chorangiosis ,business.industry ,Infant, Newborn ,Obstetrics and Gynecology ,Thrombosis ,Chorangioma ,medicine.disease ,030220 oncology & carcinogenesis ,Pediatrics, Perinatology and Child Health ,Chorangiomatosis, coagulopathy, hydrops, thrombosis, villous capillary lesions ,Female ,Hemangioma ,business ,Chorangiomatosis - Abstract
In this paper we start illustrating our experience of multifocal chorangiomatosis with the newborn affected by massive umbilical vein thrombosis, disseminated intravascular coagulopathy and hydrops, going to a literature review of cases available.Our clinical case and the review of literature highlight how multifocal chorangiomatosis, within the three subgroups identified, is the rarer form with distinct placental features and the worst outcomes for neonates. No cases of multifocal chorangiomatosis have never been described prenatally and, for further studies, could be reasonable investigate the involvement of some growth factors like vascular endothelial growth factor and placental growth factor that could lead to a detection of a subgroup of patient at higher risk to manifest placental vascular lesions and the follow fetal and maternal complications.
- Published
- 2020
- Full Text
- View/download PDF